The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sopheon Delivers Accolade® Release 9.0

19 Nov 2013 07:00

RNS Number : 3230T
Sopheon PLC
19 November 2013
 



SOPHEON PLC

("Sopheon" or the "Company")

 

Sopheon Delivers Accolade® Release 9.0 with Major New Capabilities

Sopheon, the international provider of software, expertise, and best practices for Enterprise Innovation Performance, announced today the latest version of its Accolade innovation management solution. The new, updated and enhanced capabilities in Accolade release 9.0 demonstrates Sopheon's continued commitment to enable companies to achieve dramatic increases in sustainable, profitable revenue from their innovation and new product development investments. Accolade release 9.0 includes a range of functionality and technology advancements, including:

· Delivery of the new Accolade Roadmapping™ solution which supersedes the existing Accolade Vision Strategist™ product, taking strategic planning and alignment of markets, products and technology to a new level of capability, flexibility and intuitive graphical user interface

· Major updates to the Accolade Idea Lab™ solution for idea and concept development with a redesigned user interface, pre-configured processes, and more flexible purchase options. Idea Lab is the only full-function idea solution that is fully integrated with the entire innovation and new product development lifecycle processes.

· Enhancements to the recently introduced Accolade Innovation Planner™ solution for connecting annual operating plans (AOP) and business strategies with innovation and new product development planning.

· Advanced real-time waterline analysis for portfolio and resource planning in Accolade Portfolio Center™ to enable more interactive and responsive planning insights and analysis to make the best project and portfolio decisions and investments to produce the highest returns.

· Introduction of the new Innovation Discussions Feed that provides real-time, in-context, collaborative discussions across functional areas without the need for an external type of social networking system. This is accessible from an enhanced Accolade Mobile in compliance with iOS7 design standards.

· Continuing evolution and updates to Accolade Cloud to provide customers with complete flexibility on how they buy and deploy the Accolade solution, now and in the future, according to their prevailing circumstances.

· Simplification and streamlining of configuration, integration and on-line entry capabilities.

 

Don Sarno, Vice President of Product Development at Sopheon who has worked closely with customers and buyers over the past years, stated: "Accolade 9.0 leverages rich web user technologies to advance support for all modern browsers including Chrome on Android devices. We also added a fully redesigned experience for enterprise planning and Roadmapping. As in the past, based on our fully agile release principles, we leveraged deep relationships with many of Sopheon's industry-leading customers to help drive the new user experiences and end-user value."

Accolade® is a registered trademark of Sopheon. Chrome and Android are trademarks of Google Inc.

 For further information contact:

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEASFPFSXDFFF
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.